Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Work In Process (2017 - 2022)

Catheter Precision (VTAK) has disclosed Work In Process for 6 consecutive years, with $93000.0 as the latest value for Q1 2022.

  • Quarterly Work In Process fell 67.14% to $93000.0 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $93000.0 through Mar 2022, down 67.14% year-over-year, with the annual reading at $70000.0 for FY2021, 74.07% down from the prior year.
  • Work In Process for Q1 2022 was $93000.0 at Catheter Precision, up from $70000.0 in the prior quarter.
  • The five-year high for Work In Process was $306000.0 in Q2 2021, with the low at $37000.0 in Q3 2018.
  • Average Work In Process over 5 years is $159400.0, with a median of $94000.0 recorded in 2019.
  • The sharpest move saw Work In Process skyrocketed 217.05% in 2020, then tumbled 74.07% in 2021.
  • Over 5 years, Work In Process stood at $88000.0 in 2018, then skyrocketed by 144.32% to $215000.0 in 2019, then rose by 25.58% to $270000.0 in 2020, then crashed by 74.07% to $70000.0 in 2021, then skyrocketed by 32.86% to $93000.0 in 2022.
  • According to Business Quant data, Work In Process over the past three periods came in at $93000.0, $70000.0, and $60000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.